|
1
|
Shah KB, Inoue Y and Mehra MR: Amyloidosis
and the heart: A comprehensive review. Arch Intern Med.
166:1805–1813. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Falk RH, Alexander KM, Liao R and Dorbala
S: AL (light-chain) cardiac amyloidosis: A review of diagnosis and
therapy. J Am Coll Cardiol. 68:1323–1341. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maleszewski JJ: Cardiac amyloidosis:
Pathology, nomenclature, and typing. Cardiovasc Pathol. 24:343–350.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rosenbaum AN and Edwards BS: Current
indications, strategies, and outcomes with cardiac transplantation
for cardiac amyloidosis and sarcoidosis. Curr Opin Organ
Transplant. 20:584–592. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Merlini G: CyBorD: Stellar response rates
in AL amyloidosis. Blood. 119:4343–4345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Desport E, Bridoux F, Sirac C, Delbes S,
Bender S, Fernandez B, Quellard N, Lacombe C, Goujon JM, Lavergne
D, et al: Al amyloidosis. Orphanet J Rare Dis. 7:542012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wechalekar AD, Gillmore JD and Hawkins PN:
Systemic amyloidosis. Lancet. 387:2641–2654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wechalekar AD, Gillmore JD and Hawkins PN:
Cardiac amyloidosis: An approach to diagnosis and management.
Expert Rev Cardiovasc Ther. 8:1007–1013. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Selvanayagam JB, Hawkins PN, Paul B,
Myerson SG and Neubauer S: Evaluation and management of the cardiac
amyloidosis. J Am Coll Cardiol. 50:2101–2110. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karafiatova L and Pika T: Amyloid
cardiomyopathy. Biomed Pap Med Fac Univ Palacky Olomouc Czech
Repub. 161:117–127. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng D, Edwards WD, Oh JK, Chandrasekaran
K, Grogan M, Martinez MW, Syed IS, Hughes DA, Lust JA, Jaffe AS, et
al: Intracardiac thrombosis and embolism in patients with cardiac
amyloidosis. Circulation. 116:2420–2426. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng D, Syed IS, Martinez M, Oh JK, Jaffe
AS, Grogan M, Edwards WD, Gertz MA and Klarich KW: Intracardiac
thrombosis and anticoagulation therapy in cardiac amyloidosis.
Circulation. 119:2490–2497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cho KH, Cho YM and Kim JS: Embolic
infarction associated with cardiac amyloidosis. J Clin Neurol.
1:92–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rice GP, Ebers GC, Newland F and Wysocki
GP: Recurrent cerebral embolism in cardiac amyloidosis. Neurology.
31:904–907. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bøtker HE and Rasmussen OB: Recurrent
cerebral embolism in cardiac amyloidosis. Int J Cardiol. 13:81–83.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Owa M, Takei Y, Hashikura Y, Kawasaki S,
Koyama M and Ikeda S: Recurrent cerebral embolism in a familial
amyloid polyneuropathy patient who received partial liver
transplantation from a living donor. Intern Med. 40:259–264. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamano M, Azuma A, Yazaki M, Ikeda S,
Sawada T and Matsubara H: Early cardiac involvement in senile
systemic amyloidosis: A case report. Amyloid. 15:54–59. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gillmore JD, Booth DR, Pepys MB and
Hawkins PN: Hereditary cardiac amyloidosis associated with the
transthyretin Ile122 mutation in a white man. Heart. 82:e21999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saux A, Heroum C, Sportouch C, De Graeve
F, Lequellec A and Pagès M: Amyloid cardiomyopathy: A rare cause of
cerebral embolism. Rev Neurol (Paris). 162:1128–1130. 2006.(In
French). View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yusuf SW, Solhpour A, Banchs J,
Lopez-Mattei JC, Durand JB, Iliescu C, Hassan SA and Qazilbash MH:
Cardiac amyloidosis. Expert Rev Cardiovasc Ther. 12:265–277. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ritts AJ, Cornell RF, Swiger K, Singh J,
Goodman S and Lenihan DJ: Current concepts of cardiac amyloidosis:
Diagnosis, clinical management, and the need for collaboration.
Heart Fail Clin. 13:409–416. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mankad AK, Sesay I and Shah KB:
Light-chain cardiac amyloidosis. Curr Probl Cancer. 41:144–156.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rahman JE, Helou EF, Gelzer-Bell R,
Thompson RE, Kuo C, Rodriguez ER, Hare JM, Baughman KL and Kasper
EK: Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J
Am Coll Cardiol. 43:410–415. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cacoub P, Axler O, De Zuttere D, Hausfater
P, Amoura Z, Walter S, Wechsler B, Godeau P and Piette JC:
Amyloidosis and cardiac involvement. Ann Med Interne (Paris).
151:611–617. 2000.PubMed/NCBI
|
|
25
|
Palladini G, Barassi A, Klersy C,
Pacciolla R, Milani P, Sarais G, Perlini S, Albertini R, Russo P,
Foli A, et al: The combination of high-sensitivity cardiac troponin
T (hs-cTnT) at presentation and changes in N-terminal natriuretic
peptide type B (NT-proBNP) after chemotherapy best predicts
survival in AL amyloidosis. Blood. 116:3426–3430. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kumar S, Dispenzieri A, Lacy MQ, Hayman
SR, Leung N, Zeldenrust SR, Buadi FK, Kyle RA, Rajkumar SV and
Gertz MA: Serum uric acid: Novel prognostic factor in primary
systemic amyloidosis. Mayo Clin Proc. 83:297–303. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kumar SK, Gertz MA, Lacy MQ, Dingli D,
Hayman SR, Buadi FK, Short-Detweiler K, Zeldenrust SR, Leung N,
Greipp PR, et al: Recent improvements in survival in primary
systemic amyloidosis and the importance of an early mortality risk
score. Mayo Clin Proc. 86:12–18. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dispenzieri A, Lacy MQ, Katzmann JA,
Rajkumar SV, Abraham RS, Hayman SR, Kumar SK, Clark R, Kyle RA,
Litzow MR, et al: Absolute values of immunoglobulin free light
chains are prognostic in patients with primary systemic amyloidosis
undergoing peripheral blood stem cell transplantation. Blood.
107:3378–3383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zubkov AY, Rabinstein AA, Dispenzieri A
and Wijdicks EF: Primary systemic amyloidosis with ischemic stroke
as a presenting complication. Neurology. 69:1136–1141. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roberts WC and Waller BF: Cardiac
amyloidosis causing cardiac dysfunction: Analysis of 54 necropsy
patients. Am J Cardiol. 52:137–146. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Santarone M, Corrado G, Tagliagambe LM,
Manzillo GF, Tadeo G, Spata M and Longhi M: Atrial thrombosis in
cardiac amyloidosis: Diagnostic contribution of transesophageal
echocardiography. J Am Soc Echocardiogr. 12:533–536. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hausfater P, Costedoat-Chalumeau N, Amoura
Z, Cacoub P, Papo T, Grateau G, Leblond V, Godeau P and Piette JC:
AL cardiac amyloidosis and arterial thromboembolic events. Scand J
Rheumatol. 34:315–319. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sucker C, Hetzel GR, Grabensee B,
Stockschlaeder M and Scharf RE: Amyloidosis and bleeding:
Pathophysiology, diagnosis, and therapy. Am J Kidney Dis.
47:947–955. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Melo TP, Bogousslavsky J, Regli F and
Janzer R: Fatal hemorrhage during anticoagulation of cardioembolic
infarction: Role of cerebral amyloid angiopathy. Eur Neurol.
33:9–12. 1993. View Article : Google Scholar : PubMed/NCBI
|
